$111.58
3.70% (Daily)
Market Cap
$4.32B
Revenue
$1.18B
Rank by MCap
#981
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Joseph J. Ciaffoni
Headquarters
North Chesterfield, VA
Employees
1,030
Indivior Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
Loading chart…